The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Contract Manufacturing and Contract Market Research Report 2023

Global Pharmaceutical Contract Manufacturing and Contract Market Research Report 2023

Publishing Date : Jan, 2023

License Type :
 

Report Code : 1705554

No of Pages : 112

Ask Your Query

Synopsis
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Highlights
The global Pharmaceutical Contract Manufacturing and Contract market was valued at US$ 93930 million in 2022 and is anticipated to reach US$ 136290 million by 2029, witnessing a CAGR of 6.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing and Contract, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacturing and Contract.
The Pharmaceutical Contract Manufacturing and Contract market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharmaceutical Contract Manufacturing and Contract market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Manufacturing and Contract companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • Boehringer Ingelheim
  • Fareva
  • Recipharm
  • Aenova
  • AbbVie
  • Baxter
  • Nipro Corp
  • Sopharma
  • Famar
  • Vetter
  • Shandong Xinhua
  • Piramal
  • Mylan
  • Dr. Reddy’s
  • Zhejiang Hisun
  • Zhejiang Huahai
  • Jubilant

Segment by Type

  • Oral
  • Injectable
  • API
  • Other

Segment by Application

  • Small Medium Enterprise
  • Large Enterprise

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Manufacturing and Contract Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Perspective (2018-2029)
2.2 Pharmaceutical Contract Manufacturing and Contract Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2024-2029)
2.3 Pharmaceutical Contract Manufacturing and Contract Market Dynamics
2.3.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
2.3.2 Pharmaceutical Contract Manufacturing and Contract Market Drivers
2.3.3 Pharmaceutical Contract Manufacturing and Contract Market Challenges
2.3.4 Pharmaceutical Contract Manufacturing and Contract Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical Contract Manufacturing and Contract Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Manufacturing and Contract Revenue
3.4 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacturing and Contract Revenue in 2022
3.5 Pharmaceutical Contract Manufacturing and Contract Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Type
4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application
5.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
6.2 North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
6.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
7.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
9.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
11.3.4 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
11.5.4 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Detail
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
11.7.4 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Detail
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
11.9.4 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Detail
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Detail
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Detail
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
11.12.4 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Detail
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
11.13.4 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Detail
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Detail
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
11.15.4 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
11.16.4 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Detail
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Detail
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Detail
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Detail
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of API
Table 5. Key Players of Other
Table 6. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2018-2023)
Table 10. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2024-2029)
Table 12. Pharmaceutical Contract Manufacturing and Contract Market Trends
Table 13. Pharmaceutical Contract Manufacturing and Contract Market Drivers
Table 14. Pharmaceutical Contract Manufacturing and Contract Market Challenges
Table 15. Pharmaceutical Contract Manufacturing and Contract Market Restraints
Table 16. Global Pharmaceutical Contract Manufacturing and Contract Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players (2018-2023)
Table 18. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacturing and Contract as of 2022)
Table 19. Ranking of Global Top Pharmaceutical Contract Manufacturing and Contract Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
Table 23. Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2018-2023)
Table 27. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2024-2029)
Table 29. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2018-2023)
Table 31. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2024-2029)
Table 33. North America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 48. Catalent Company Detail
Table 49. Catalent Business Overview
Table 50. Catalent Pharmaceutical Contract Manufacturing and Contract Product
Table 51. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 52. Catalent Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product
Table 56. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Lonza Company Detail
Table 59. Lonza Business Overview
Table 60. Lonza Pharmaceutical Contract Manufacturing and Contract Product
Table 61. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 62. Lonza Recent Development
Table 63. Boehringer Ingelheim Company Detail
Table 64. Boehringer Ingelheim Business Overview
Table 65. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product
Table 66. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 67. Boehringer Ingelheim Recent Development
Table 68. Fareva Company Detail
Table 69. Fareva Business Overview
Table 70. Fareva Pharmaceutical Contract Manufacturing and Contract Product
Table 71. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 72. Fareva Recent Development
Table 73. Recipharm Company Detail
Table 74. Recipharm Business Overview
Table 75. Recipharm Pharmaceutical Contract Manufacturing and Contract Product
Table 76. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 77. Recipharm Recent Development
Table 78. Aenova Company Detail
Table 79. Aenova Business Overview
Table 80. Aenova Pharmaceutical Contract Manufacturing and Contract Product
Table 81. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 82. Aenova Recent Development
Table 83. AbbVie Company Detail
Table 84. AbbVie Business Overview
Table 85. AbbVie Pharmaceutical Contract Manufacturing and Contract Product
Table 86. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 87. AbbVie Recent Development
Table 88. Baxter Company Detail
Table 89. Baxter Business Overview
Table 90. Baxter Pharmaceutical Contract Manufacturing and Contract Product
Table 91. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 92. Baxter Recent Development
Table 93. Nipro Corp Company Detail
Table 94. Nipro Corp Business Overview
Table 95. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product
Table 96. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 97. Nipro Corp Recent Development
Table 98. Sopharma Company Detail
Table 99. Sopharma Business Overview
Table 100. Sopharma Pharmaceutical Contract Manufacturing and Contract Product
Table 101. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 102. Sopharma Recent Development
Table 103. Famar Company Detail
Table 104. Famar Business Overview
Table 105. Famar Pharmaceutical Contract Manufacturing and Contract Product
Table 106. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 107. Famar Recent Development
Table 108. Vetter Company Detail
Table 109. Vetter Business Overview
Table 110. Vetter Pharmaceutical Contract Manufacturing and Contract Product
Table 111. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 112. Vetter Recent Development
Table 113. Shandong Xinhua Company Detail
Table 114. Shandong Xinhua Business Overview
Table 115. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product
Table 116. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 117. Shandong Xinhua Recent Development
Table 118. Piramal Company Detail
Table 119. Piramal Business Overview
Table 120. Piramal Pharmaceutical Contract Manufacturing and Contract Product
Table 121. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 122. Piramal Recent Development
Table 123. Mylan Company Detail
Table 124. Mylan Business Overview
Table 125. Mylan Pharmaceutical Contract Manufacturing and Contract Product
Table 126. Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 127. Mylan Recent Development
Table 128. Dr. Reddy’s Company Detail
Table 129. Dr. Reddy’s Business Overview
Table 130. Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product
Table 131. Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 132. Dr. Reddy’s Recent Development
Table 133. Zhejiang Hisun Company Detail
Table 134. Zhejiang Hisun Business Overview
Table 135. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product
Table 136. Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 137. Zhejiang Hisun Recent Development
Table 138. Zhejiang Huahai Company Detail
Table 139. Zhejiang Huahai Business Overview
Table 140. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product
Table 141. Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 142. Zhejiang Huahai Recent Development
Table 143. Jubilant Company Detail
Table 144. Jubilant Business Overview
Table 145. Jubilant Pharmaceutical Contract Manufacturing and Contract Product
Table 146. Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 147. Jubilant Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Manufacturing and Contract Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injectable Features
Figure 5. API Features
Figure 6. Other Features
Figure 7. Global Pharmaceutical Contract Manufacturing and Contract Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2022 VS 2029
Figure 9. Small Medium Enterprise Case Studies
Figure 10. Large Enterprise Case Studies
Figure 11. Pharmaceutical Contract Manufacturing and Contract Report Years Considered
Figure 12. Global Pharmaceutical Contract Manufacturing and Contract Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Pharmaceutical Contract Manufacturing and Contract Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region: 2022 VS 2029
Figure 15. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players in 2022
Figure 16. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacturing and Contract as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue in 2022
Figure 18. North America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2018-2029)
Figure 20. United States Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2018-2029)
Figure 24. Germany Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2018-2029)
Figure 32. China Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2018-2029)
Figure 40. Mexico Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Share by Country (2018-2029)
Figure 44. Turkey Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Catalent Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 48. Lonza Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 50. Fareva Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 51. Recipharm Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 52. Aenova Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 53. AbbVie Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 54. Baxter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 55. Nipro Corp Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 56. Sopharma Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 57. Famar Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 58. Vetter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 59. Shandong Xinhua Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 60. Piramal Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 61. Mylan Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 62. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 63. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 64. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 65. Jubilant Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock